Nuclear Medicine in the Assessment of Adverse Effects of Cancer Therapy in the Lung, Kidney, and Gastrointestinal Tract

Aug 20, 2016 by in NUCLEAR MEDICINE Comments Off on Nuclear Medicine in the Assessment of Adverse Effects of Cancer Therapy in the Lung, Kidney, and Gastrointestinal Tract

Fig. 30.1 Patient with Hodgkin’s lymphoma treated with bleomycin. Diffuse bilateral uptake of 67Ga-citrate reflects pulmonary toxicity Recently, pulmonary [18F]FDG uptake has been reported in patients with BIP and absence…

read more

Brain Tumors

Aug 20, 2016 by in NUCLEAR MEDICINE Comments Off on Brain Tumors

Tumors of neuroepithelial tissue  Tumors of the pineal region  Angiolipoma 8861/0 Astrocytic tumors  Pineocytoma 9361/1 Hibernoma 8880/0 Pilocytic astrocytoma 9421/1a Pineal parenchymal tumor of intermediate differentiation 9362/3 Liposarcoma 8850/3 Pilomyxoid…

read more

131I-MIBG Therapy

Aug 20, 2016 by in NUCLEAR MEDICINE Comments Off on 131I-MIBG Therapy

Fig. 26.1 (a) Serial 123I-MIBG posterior whole body images from a patient with unresectable primary PHEO of the right adrenal (upper arrows) and metastatic disease to retroperitoneal nodes (lower arrows),…

read more

Lymphomas

Aug 20, 2016 by in NUCLEAR MEDICINE Comments Off on Lymphomas

  Factors  IPS [21] Male gender Age >45 Stage 4 Hemoglobin <10.5 g/L WBC count >15  ×  109/L Lymphocyte count <0.6  ×  109/L or <8% WBC Serum albumin <40 g/L…

read more

Imaging the Heart in the Cancer Patient

Aug 20, 2016 by in NUCLEAR MEDICINE Comments Off on Imaging the Heart in the Cancer Patient

(1) Section of Nuclear Medicine, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA (2) Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA   Abstract…

read more

Kidney and Bladder Cancer

Aug 20, 2016 by in NUCLEAR MEDICINE Comments Off on Kidney and Bladder Cancer

Fig. 20.1 Observed survival rates for 37,166 patients with kidney cancer classified by the current AJCC staging classification. Data taken from the National Cancer Data Base (Commission on Cancer of…

read more

Gastric Cancers

Aug 20, 2016 by in NUCLEAR MEDICINE Comments Off on Gastric Cancers

Group T category N category M category Stage 0 Tis N0 M0 Stage IA T1 N0 M0 Stage IB T2 N0 M0 T1 N1 M0 Stage IIA T3 N0 M0…

read more

Targeted Therapy for Bone Metastasis

Aug 20, 2016 by in NUCLEAR MEDICINE Comments Off on Targeted Therapy for Bone Metastasis

Isotope Compound Half-life (days) b-energy (MeV) (maximum) g-energy (MeV) (%) Soft tissue range (mm) (maximum) 32P 32P-phosphate 14.3 1.71 – 8 89Sr 89Sr-chloride 50.5 1.46 0.91 (0.01) 2.4 186Re 186Re-HEDP…

read more
Get Clinical Tree app for offline access